The risk of cancer goes up with age, in part because aging impedes the body's ability to detect and destroy cells with ...

Researchers at Mayo Clinic's Center for Individualized Medicine have discovered a rare genetic variant that can directly ...

Gain valuable insights into novel therapies, ongoing clinical trials, and future innovations shaping the treatment of ...

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

Cirrhosis progresses in stages, from a compensated phase with few symptoms to a decompensated phase with serious ...

The prevalence of fatty liver disease is surging among young adults, posing a rising public health challenge. Experts ...

Fatigue and yellowing eyes may signal hepatitis, a serious liver issue. Learn the symptoms, causes, prevention, and available ...

The liver, often called the body’s silent protector, performs over 500 essential functions, including digestion, ...

Fatty liver disease, now called MASLD, which stands for Metabolic Dysfunction-Associated Steatotic Liver Disease, is a silent epidemic affecting around 100 million Americans. That means, because of el ...

An AI-based algorithm may help detect chronic liver disease using images from standard echocardiography, according to study ...

Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin-3 for patients with MASH cirrhosis and portal hypertension, today announced that it will attend the ...

It is the fourth leading cause of cancer-related deaths worldwide ... The risk factors for developing HCC are primarily ...